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Highlights: 
• There were marked discrepancies between sources 
• Patient organisations preferentially recommended medicines, pacing and 
complementary treatments 
• Medical organisations recommended rehabilitation therapies 
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ABSTRACT 
Objectives : Chronic fatigue syndrome (CFS) is a controversial illness, with apparent 
disagreements between medical authorities and patient support organisations 
regarding safe and effective treatments.  The aim of this study was to measure the 
extent of different views regarding treatments, comparing patient support 
organisations and medical authorities in the UK. 
Methods: Two independent raters analysed two groups of resources: UK patient 
support websites and both medical websites and textbooks.  A 5-point Likert scale 
was developed with the question ‘With what strength does the source recommend 
these treatments?’  The various treatments were divided into the following four 
groups: complementary and alternative medicine (CAM), pharmacological, 
rehabilitative, and pacing therapies. 
Results: There were significant differences between the scores for patient support 
organisations and medical authorities for all 4 treatment groups.  The results for 
supporting CAM were 74% (patient group) vs 16% (medical authority) (p<0.001), 
71% vs 42% for pharmacological (p=0.01), 28% vs 94% for rehabilitative (p<0.001) 
and 91% vs 50% for pacing treatments (p=0.001). 
Conclusions: There were substantially different treatment recommendations between 
patient support organisations and medical authorities. Since expectations can 
determine response to treatment, these different views may reduce the engagement in 
and effectiveness of rehabilitative therapies recommended by national guidelines and 
supported by systematic reviews.   
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Introduction 
Chronic fatigue syndrome (CFS), also named myalgic encephalomyelitis (ME), is a 
condition that still creates debates regarding definition, aetiology, diagnosis and 
treatment [1]. The condition is found world-wide, with a meta-analysis suggesting a 
prevalence of 0.76% [2].  Treatment trials  have focused on rehabilitation therapies  
[3]. People with CFS/ME can receive conflicting treatment options from medical 
sources and patient support organisations. 
 
The National Institute of Health and Care Excellence (NICE) guidelines on CFS/ME 
[4] have been subject to criticisms from some patient organisations on the basis that 
they consider the main treatments recommended by NICE, namely cognitive 
behaviour therapy (CBT) and graded exercise therapy (GET), as either unsafe or 
unhelpful. [5,6]. Some CFS/ME patient support organisations have claimed that NICE 
has overlooked the physical component of the illness [6]. Of relevance to this, 
Hossenbaccus and White found that patient support organisations considered CFS/ME 
to be a physical disease, whereas medical authorities were more likely to consider 
CFS/ME as being a combination of physical and psychological factors [7]. 
 
The UK based PACE trial agreed with the NICE guidelines [4], finding that CBT and 
GET, when combined with specialist care, were safe and effective treatments for 
CFS/ME, whereas pacing was ineffective [3]. Some patient support organisations 
have continued to promote a pacing approach [5, 7, 8, 9]. 
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Stories about CFS/ME are often reported in the media and online forums are 
expanding [1, 7, 10]. For illnesses such as CFS/ME, where recommended treatments 
are not universally supported, patients can search for alternative treatments through 
forums and patient organisations.   
 
Knudsen et al [1], found that newspaper articles in Norway were generally positive 
towards alternative treatment and negative towards evidence-based treatments 
(mainly CBT and GET); patients preferred alternative treatments; physicians favoured 
evidence based treatments; and the Norwegian ME association was critical of  
evidence-based treatments [1].   
 
We are not aware of any published studies of views of treatments comparing patient 
support groups and medical authorities. This study aimed to determine whether there 
were significant differences between which treatments were recommended, or 
discouraged, between these two groups. We predicted that patient groups would 
favour pharmacological, complementary and alternative (CAM) treatments, and 
pacing, whereas medical sources would prefer rehabilitative based therapies. 
 
Methods 
A database was created using both internet searches and a catalogue of CFS/ME 
patient organisations previously used in the study by Hossenbaccus and White (see 
supplementary material) [7]. The medical sources group was comprised of websites 
from medical Royal Colleges, the UK National Health Service, NICE, the Department 
of Health and British United Patients Association, together with textbooks found in 
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the medical school library of Barts and the London. The appendix contains all sources 
reviewed. 
 
The different types of treatment were grouped under the following general headings: 
Complementary and alternative medicine (CAMs), pharmacological treatment, 
rehabilitative based therapies (CBT and GET) and pacing.   
 
The primary question used for scoring of each source was as follows, ‘With what 
strength does the source recommend these treatments?’  After a pilot study, a five 
point Likert scale guided the scoring.  A score of 5 was given if the source was 
strongly supportive, stated a benefit or that they recommended the treatment.  A score 
of 4 indicated being moderately supportive, or specifically recommended for 
symptomatic relief, which particularly applied to pharmacological treatment. A score 
of 3 was given if the treatment was mentioned in the source, but there was no 
indication whether the authors supported or rejected the treatment.  A score of 2 
indicated that the author was moderately unsupportive of a treatment.  A score of 1 
indicated that the source was strongly against or clearly not recommending the 
treatment. Each individual treatment mentioned was scored individually, and a 
composite mean calculated as a final score for each treatment. All sources were 
reviewed in 2015. Ratings were made independently by two raters, and any 
discrepancies in scoring were discussed and re-evaluated consensually.   
 
The analysis of this study was done using the SPSS software version 22, using the 
agreed mean scores. An inter-rater reliability analysis was undertaken, using intra-
class correlations for interval data. Frequencies were assessed and quartiles and 
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median values derived for each treatment group for the two sources, since the data 
were not normally distributed.  Non-parametric Mann-Whitney U tests were then 
carried out to compare scores from the two sources. 
 
Results 
The total number of sources used for analysis was 95, with 60 medical authorities and 
35 CFS/ME patient support organisations surveyed.  Not all sources mentioned every 
treatment group; so numbers of sources for each treatment group were 48, 65, 81 and 
38 for CAM, pharmacological, rehabilitative and pacing respectively. The two raters 
sought and achieved consensus for 37 mean scores out of 380 (10%). The intra-class 
correlation between independent raters’ scores was 0.96 (P < 0.001) with a median 
(quartiles) difference in scores, when one was present, of 0.3 (0.025, 1.0) points. 
 
Frequencies for the different treatment groups for CFS/ME patient support 
organisations and medical authorities are shown in table 1 and further demonstrated in 
figure 1.  Here, a positive score is an agreed mean score greater than 3, a negative 
score is less than 3 and neutral is a score of 3. 
 
Descriptive statistics of the data for CFS/ME patient support organisations 
demonstrated the median (quartiles) for CAM, pharmacological, rehabilitative and 
pacing treatment groups to be 4.0 (3.0, 4.2), 4.0 (3.0, 4.3), 3.0 (1.5, 3.5) and 5.0 (4.0, 
5.0) respectively, and 1.5 (1.0, 3.0), 2.9 (2.0, 4.0), 4.5 (4.0, 5.0) and 3.3 (2.3, 4.0) for 
the medical authorities respectively. There were significant differences in the scores 
between patient support organisations and medical authorities for every treatment 
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group (CAM p < 0.001, pharmacological p = 0.011, rehabilitative p < 0.001 and 
pacing p = 0.001).  
 
Discussion 
There were significantly different recommendations between CFS/ME patient support 
organisations and medical sources across all four treatment groups. Whilst patient 
support organisations favoured CAMs, pharmacological and pacing therapies, about 
half were against rehabilitative therapies. The medical authorities viewed CAMs 
negatively, and recommended rehabilitative treatment.   
 
These findings  support our hypotheses and support the finding from Knudsen et al. 
[1]. Together with the study by Hossenbaccus and White [7], this study provides an 
insight into the reasons for these discrepancies; patient support organisations seem to 
prefer treatments that reinforce the physiological or physical view of CFS/ME, and 
reject the more behavioural therapies contained within the rehabilitative group. The 
reticence of patient organisations to recommend rehabilitative therapies may also be 
related to instances of poor delivery of these therapies [8]. It should be remembered 
that the moderate success of behavioural approaches does not imply that CFS/ME is a 
psychological or psychiatric disorder. Such dualistic beliefs should have no place in 
modern medical understanding of conditions such as CFS/ME [7, 10, 11]. 
 
In this study it was possible to score a large number of sources, including all available 
UK based CFS/ME patient support organisations that had a website, and a large 
number of medical textbooks and websites. The high intra-class correlation between 
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independent rating scores suggests a reliable scoring method, although raters with 
different backgrounds may have rated sources differently.   
 
Limitations included the subjective nature of analysing language, as well as minor 
variations between the independent rater scores.  Furthermore, the raters were unable 
to be blinded to the source. Both raters were medical students, and it may be that 
other raters, such as patient group members, might have obtained different scores. 
There were also fewer patient support organisations sources (N=35), compared to 
medical authorities (N=60). 
 
The findings from this study inform healthcare professionals about what types of 
treatments are commonly recommended by patient support groups on the internet, and 
that this may conflict with established treatment guidelines. This may additionally 
have an effect on the response and expectations of patients; Cho et al [12] 
demonstrated that CFS/ME patients respond to the treatment that best reflects their 
views on the illness. CFS/ME is almost unique within medicine in having such a 
marked discrepancy of views between patient organisations and medical authorities,  
although another example is chronic  Lyme disease [9, 13]. These discrepancies are 
often based on different understanding of the concepts of illness and disease [14], as 
well as using different language to describe similar approaches, such as baseline 
setting and pacing [8]. 
 
Further investigations into the reasons for the differences in opinion might help 
reduce the discrepancies regarding treatment recommendation from different sources 
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[8].  Research in countries with different healthcare systems would further provide 
insight into whether these discrepancies are world-wide. 
 
In conclusion, although much is still in dispute in regards to CFS/ME, it is 
undoubtedly a debilitating illness, and clinicians need to be able to provide treatment 
as well as advice regarding whether to join a patient organisation [4]. Work needs to 
be done to establish a common understanding regarding treatment recommendations 
between medical sources and patient support organisations in order to provide 
consistent advice to patients about the most effective and safest treatments available. 
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Figure 1 
Frequencies of views for each treatment group 
 
Fig 1: Frequencies of positive and negative opinions for each treatment group. Neutral results have been omitted. 
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Table 1 
Frequencies of views for each treatment group 
 
Treatment Group Organisation 
Positive Neutral Negative 
Frequency (%) Frequency (%) Frequency (%) 
CAM Patient 17/23 (74) 5/23 (22) 1/23 (4) 
 
Medical 4/25 (16) 3/25 (12) 18/25 (72) 
Pharmacological Patient 12/17 (71) 2/17 (11) 3/17 (18) 
 
Medical 20/48 (42) 4/48 (8) 24/48 (50) 
Rehabilitative Patient 6/21 (28) 5/21 (24) 10/21 (48) 
 
Medical 56/60 (94) 2/60 (3) 2/60 (3) 
Pacing Patient 20/22 (91) 2/22 (9) 0/22 (0) 
 
Medical 8/16 (50) 4/16 (25) 4/16 (25) 
 
CAM  = Complementary and Alternative Medicines. A positive score is a mean score greater than 3, negative is 
less than 3 and neutral is a mean score of 3.   
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Highlights: 
• There were marked discrepancies between sources 
• Patient organisations preferentially recommended medicines, pacing and 
complementary treatments 
• Medical organisations recommended rehabilitation therapies 
